Unknown

Dataset Information

0

Histone deacetylase-mediated regulation of the antimicrobial peptide hBD2 differs in intestinal cell lines and cultured tissue.


ABSTRACT: Histone deacetylase inhibition (HDACi) has been suggested as a promising approach to bolster TLR-mediated induction of antimicrobial peptides such as human ?-defensin 2 (hBD2). In inflammatory bowel disease (IBD), Crohn's disease (CD) patients display an attenuated expression of hBD2 as compared to ulcerative colitis (UC). Here, we aimed to study if combining HDACi with the therapeutic E. coli Nissle 1917 (EcN), a strong hBD2 inducer, might be a feasible strategy to further modify protective immune responses. Monolayer epithelial cell lines versus cultured human biopsies from healthy controls and CD and UC patients showed diverse effects. In mono-cell systems, we observed a strong NF-kB-dependent enhancement of TLR- but also IL1?-mediated hBD2 induction after HDACi. In contrast, multicellular colonic biopsy culture showed the opposite result and HDACi was associated with an abolished TLR-mediated hBD2 induction in all tested patient groups. Of note, CD patients showed an attenuated induction of hBD2 by E. coli Nissle as compared to UC. We conclude that the role of HDACs in hBD2 regulation is context-dependent and likely modified by different cell types. Differential induction in different IBD entities suggests different clinical response patterns based on still unknown hBD2-associated mechanisms.

SUBMITTER: Stebe-Frick S 

PROVIDER: S-EPMC6110836 | biostudies-other | 2018 Aug

REPOSITORIES: biostudies-other

altmetric image

Publications

Histone deacetylase-mediated regulation of the antimicrobial peptide hBD2 differs in intestinal cell lines and cultured tissue.

Stebe-Frick Sabrina S   Ostaff Maureen J MJ   Stange Eduard F EF   Malek Nisar P NP   Wehkamp Jan J  

Scientific reports 20180827 1


Histone deacetylase inhibition (HDACi) has been suggested as a promising approach to bolster TLR-mediated induction of antimicrobial peptides such as human β-defensin 2 (hBD2). In inflammatory bowel disease (IBD), Crohn's disease (CD) patients display an attenuated expression of hBD2 as compared to ulcerative colitis (UC). Here, we aimed to study if combining HDACi with the therapeutic E. coli Nissle 1917 (EcN), a strong hBD2 inducer, might be a feasible strategy to further modify protective imm  ...[more]

Similar Datasets

| S-EPMC4889416 | biostudies-literature
2016-05-23 | GSE80048 | GEO
| S-EPMC2636857 | biostudies-literature
| S-EPMC5140276 | biostudies-literature
| S-EPMC3949438 | biostudies-literature
| S-EPMC7708062 | biostudies-literature
| S-EPMC5936830 | biostudies-literature
| S-EPMC3710791 | biostudies-literature
| S-EPMC3903896 | biostudies-literature
| S-EPMC2234368 | biostudies-literature